AJO

Audio Journal of Oncology 12.9, December 2004

December 8, 2004 ⋅ Post a comment

Reporting from:
- 4th European Breast Cancer Conference, March 16-20, 2004, Hamburg
- 6th International Symposium on Hodgkin’s Lymphoma
- 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, September 28-October 1, 2004, Geneva
- Journal of Clinical Oncology
- New England Journal of Medicine
- Lancet
- British Journal of Cancer

In this edition:

Ian Smith questions the routine use of radiotherapy for patients with breast cancer treated with lumpectomy in the light of two publications and his editorial in the New England Journal of Medicine.

The molecularly targeted drug cetuximab could be reversing irinotecan resistance in patients with metastatic colorectal cancer, according to Naureen Starling and Eric van Cutsem.

The usefulness of adjuvant chemotherapy in patients with stage II colon cancer is discussed by George Canellos and Gordon McVie following publications in the Journal of Clinical Oncology.

An analog of thalidomide shows promise for treating patients with relapsed, refractory myeloma, according to Steven Schey.

In a group of patients with hormone-refractory metastatic prostate cancer, Alison Birtle has found a non-taxane regimen to be as promising as the recent results using docetaxel.

Click here for more.

Similar Interviews

  • Audio Journal of Oncology 13.3, April 2005

    • Reporting from: - American Society of Hematology 46th Annual Meeting, December 4-7, 2004, San Diego - San Antonio Breast Cancer Symposium, December

  • Audio Journal of Oncology 13.2, February 2005

    • Reporting from: - Annual Meeting of the American Society of Hematology, December 4-7, 2004, San Diego - Chemotherapy Foundation Symposium, November 10-13

  • Audio Journal of Oncology Breast Cancer Special 2005

    • Reporting from: - San Antonio Breast Cancer Symposium, December 8-11, 2004 - European Society for Medical Oncology Congress, October 29-November 10, 2004,

    Post a comment

    LDL-How Low?»
    Terje Pedersen, Ulleval University, Oslo
    Lowering LDL Cholesterol intensively as a means of treating aortic stenosis was found to have no benefit in the SEAS (Simvastatin and Ezetimibe In Aortic Stenosis) study reported by Terje Pederson at a Hot Line session of the E.S.C. Congress. But the potential gains from such lowering in other clinical situations could be considerable, according to Eugene Braunwald who chaired the session. In Munich they talked with Peter Goodwin.
    LSHTM Audio News»
    Bayard Roberts, Siân Clarke, Sandy Cairncross, Claire Bertschinger and Virginia Berridge
    Derek Thorne and Peter Goodwin talk with Bayard Roberts, Siân Clarke, Sandy Cairncross, Claire Bertschinger and Virginia Berridge of The London School of Hygiene and Tropical Medicine about:
    - depression and post traumatic stress disorder in war-torn northern Uganda and the lessons to be drawn from a research project there; - the unexpected additional value of using malaria drugs at regular intervals among school children in Kenya; - the key role of sanitation in preventing infant deaths all over the world and what is being done to improve it; - the life and work of the nurse who inspired Band Aid and Live Aid, as she receives an honorary doctorate; - the \"marketing\" of health to the British public, as illustrated by the way attitudes to smoking have changed over the years.
    Subscribe to Audio Medica Podcast